Alembic Pharma to acquire 45% stake in Canadian venture for pharma market expansion
Alembic Pharmaceuticals Limited has executed a Shareholders’ Agreement to invest in a newly incorporated Canadian Corporation as part of its plans to expand its pharmaceutical presence in the Canadian market. The company will hold a 45% equity stake in the Canadian entity following the investment. The agreement has been entered into along with Difgen Holdings…
